BR9806871A - Processo para a preparação de omeprazol, formulação farmacêutica, e, omeprazol. - Google Patents
Processo para a preparação de omeprazol, formulação farmacêutica, e, omeprazol.Info
- Publication number
- BR9806871A BR9806871A BR9806871-7A BR9806871A BR9806871A BR 9806871 A BR9806871 A BR 9806871A BR 9806871 A BR9806871 A BR 9806871A BR 9806871 A BR9806871 A BR 9806871A
- Authority
- BR
- Brazil
- Prior art keywords
- omeprazole
- preparation
- methoxy
- pharmaceutical formulation
- benzimidazole
- Prior art date
Links
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 title abstract 6
- 229960000381 omeprazole Drugs 0.000 title abstract 6
- -1 and Chemical compound 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 230000001590 oxidative effect Effects 0.000 abstract 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 239000007800 oxidant agent Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 229910052719 titanium Inorganic materials 0.000 abstract 1
- 239000010936 titanium Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9704183A SE9704183D0 (sv) | 1997-11-14 | 1997-11-14 | New process |
| PCT/SE1998/001984 WO1999025711A1 (en) | 1997-11-14 | 1998-11-03 | New process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9806871A true BR9806871A (pt) | 2000-04-18 |
Family
ID=20408989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9806871-7A BR9806871A (pt) | 1997-11-14 | 1998-11-03 | Processo para a preparação de omeprazol, formulação farmacêutica, e, omeprazol. |
Country Status (35)
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
| US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
| IL142703A (en) | 1998-11-10 | 2006-04-10 | Astrazeneca Ab | Crystalline form of omeprazole |
| UA72748C2 (en) | 1998-11-10 | 2005-04-15 | Astrazeneca Ab | A novel crystalline form of omeprazole |
| CN100347167C (zh) | 2001-02-02 | 2007-11-07 | 特瓦制药工业有限公司 | 取代的2－(2－吡啶基甲基)亚磺酰基－1h－苯并咪唑化合物的生产方法 |
| SE0203092D0 (en) * | 2002-10-18 | 2002-10-18 | Astrazeneca Ab | Method for the synthesis of a benzimidazole compound |
| US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| SI1802584T1 (sl) * | 2004-10-11 | 2010-01-29 | Ranbaxy Lab Ltd | Postopki za pripravo substituiranih sulfoksidov |
| EP1801110A1 (en) | 2005-12-22 | 2007-06-27 | KRKA, tovarna zdravil, d.d., Novo mesto | Esomeprazole arginine salt |
| CN1810803B (zh) * | 2006-02-17 | 2010-11-17 | 中国科学院上海有机化学研究所 | 高对映体选择性制备(s)-奥美拉唑的方法 |
| CN101538264A (zh) * | 2008-03-19 | 2009-09-23 | 中国科学院成都有机化学有限公司 | 手性亚砜类化合物的制备新方法 |
| CN102603621B (zh) * | 2012-02-07 | 2013-09-04 | 成都苑东药业有限公司 | 一种新型手性亚砜化合物和以该化合物制备埃索美拉唑钠的方法 |
| CN106083819A (zh) * | 2016-06-08 | 2016-11-09 | 扬子江药业集团有限公司 | 一种奥美拉唑的制备方法 |
| ES2948511A1 (es) * | 2021-09-08 | 2023-09-13 | Fundacion Para La Investigacion Biomedica Del Hospital Univ De La Princesa | Derivados de n-sulfonilureas y su uso terapeutico |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
| FI95572C (fi) * | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
| SE9002043D0 (sv) | 1990-06-07 | 1990-06-07 | Astra Ab | Improved method for synthesis |
| WO1993006097A1 (en) | 1991-09-20 | 1993-04-01 | Merck & Co., Inc. | Novel process for the preparation of anti-ulcer agents |
| SE504459C2 (sv) * | 1994-07-15 | 1997-02-17 | Astra Ab | Förfarande för framställning av substituerade sulfoxider |
-
1997
- 1997-11-14 SE SE9704183A patent/SE9704183D0/xx unknown
-
1998
- 1998-03-11 UA UA99073870A patent/UA68342C2/uk unknown
- 1998-11-02 TW TW087118172A patent/TW588046B/zh not_active IP Right Cessation
- 1998-11-02 IN IN3213DE1998 patent/IN190801B/en unknown
- 1998-11-02 MY MYPI98004977A patent/MY118199A/en unknown
- 1998-11-02 ZA ZA989999A patent/ZA989999B/xx unknown
- 1998-11-02 AR ARP980105504A patent/AR013740A1/es unknown
- 1998-11-03 RU RU99117541/04A patent/RU2211218C2/ru not_active IP Right Cessation
- 1998-11-03 AU AU10582/99A patent/AU750743B2/en not_active Ceased
- 1998-11-03 JP JP52827799A patent/JP2001508466A/ja not_active Ceased
- 1998-11-03 PL PL98334701A patent/PL334701A1/xx unknown
- 1998-11-03 TR TR1999/01643T patent/TR199901643T1/xx unknown
- 1998-11-03 ES ES98953132T patent/ES2138950T1/es active Pending
- 1998-11-03 BR BR9806871-7A patent/BR9806871A/pt not_active Application Discontinuation
- 1998-11-03 DE DE0964859T patent/DE964859T1/de active Pending
- 1998-11-03 KR KR1019997006290A patent/KR20000070069A/ko not_active Abandoned
- 1998-11-03 US US09/194,647 patent/US6303788B1/en not_active Expired - Fee Related
- 1998-11-03 YU YU31199A patent/YU31199A/sh unknown
- 1998-11-03 SK SK872-99A patent/SK87299A3/sk unknown
- 1998-11-03 IL IL13064798A patent/IL130647A0/xx not_active IP Right Cessation
- 1998-11-03 DZ DZ980251A patent/DZ2641A1/xx active
- 1998-11-03 ID IDW990692A patent/ID21999A/id unknown
- 1998-11-03 HU HU0003737A patent/HUP0003737A3/hu unknown
- 1998-11-03 HR HR990218A patent/HRP990218A2/hr not_active Application Discontinuation
- 1998-11-03 EP EP98953132A patent/EP0964859A1/en not_active Ceased
- 1998-11-03 CN CNB988017970A patent/CN1145624C/zh not_active Expired - Fee Related
- 1998-11-03 EE EEP199900391A patent/EE04154B1/xx not_active IP Right Cessation
- 1998-11-03 NZ NZ336447A patent/NZ336447A/en unknown
- 1998-11-03 CA CA002276753A patent/CA2276753A1/en not_active Abandoned
- 1998-11-03 WO PCT/SE1998/001984 patent/WO1999025711A1/en not_active Application Discontinuation
- 1998-11-05 MA MA25335A patent/MA26564A1/fr unknown
- 1998-11-09 TN TNTNSN98202A patent/TNSN98202A1/fr unknown
-
1999
- 1999-07-02 IS IS5106A patent/IS5106A/is unknown
- 1999-07-02 NO NO19993298A patent/NO318197B1/no unknown
-
2000
- 2000-07-31 GR GR990300046T patent/GR990300046T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9806871A (pt) | Processo para a preparação de omeprazol, formulação farmacêutica, e, omeprazol. | |
| BR9915852A (pt) | Conjugado de hapteno-portador para tratamento e prevenção do vìcio da nicotina | |
| CL2009000805A1 (es) | Composicion farmaceutica que comprende a una sal sodica del enantiomero (-) de 5-metoxi-2[[(4-metoxi-3,5-dimetil-2-piridinil)metil]sulfinil]-1h-bencimidazol ((-)-omeprazol); y su uso en la inhibicion de la secrecion de acido gastrico y para tratar enfermedades inflamatorias gastrointestinales. (divisional solicitud 3570-00). | |
| ATE94063T1 (de) | Verwendung von omeprazol als antimikrobielles mittel. | |
| AR010361A1 (es) | "S-OMEPRAZOL [ENANTIoMERO S DE 5-METOXI-2-[[(4--METOXI-3,5-DIMETIL-2-PIRIDINIL)-METIL]SULFINIL]-1H-BENCIMIDAZOL], EN UNA FORMA NEUTRA NO SALINA, PROCESO PARA SU PREPARACION, COMPOSICION FARMACEUTICA, Y SU USO PARA LA MANUFACTURA DE MEDICAMENTOS" | |
| BR0108584A (pt) | Formulações contendo um fármaco anticolinérgico para o tratamento da broncopneumopatia crÈnica obtrutiva | |
| NO308771B1 (no) | Filmbelagt, oralt doseringspreparat med forlenget frigivelse | |
| NO934500L (no) | Ikke-klorfluorcarbonaerosolformuleringer | |
| SE9702000D0 (sv) | New pharmaceutical formulation | |
| TR200102138T2 (tr) | (S)-Omeprazolün potasyum tuzu. | |
| CO4750654A1 (es) | Proceso para la sintesis de un compuesto omeprazol | |
| ATE116843T1 (de) | Lösungsmittelfreie, oral zu verabreichende pharmazeutische zubereitung mit verzögerter wirkstofffreisetzung und verfahren zu deren herstellung. | |
| LV10268A (lv) | Terapeitiski aktivs benzimidazols un ta iegusanas panemiens | |
| DE60216273D1 (de) | Kristalline form von omeprazol | |
| ATE269057T1 (de) | Arzneizubereitungen und deren herstellungsverfahren | |
| NO178336C (no) | Analogifremgangsmåte for fremstilling av en terapeutisk aktiv benzimidazolforbindelse og mellomprodukter | |
| BR0112984A (pt) | Sais tartarato de derivado de tiazolidinodiona | |
| DE60010230D1 (de) | Pharmazeutische zusammensetzung von hydrophob modifizierten hedgehog-proteinen und deren verwendung | |
| IT1271434B (it) | Composizione farmaceutica avente attivita' antiasmatica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TC | Change of name | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |